Cargando…
The design of experiments (DoE) in optimization of an aerobic flow Pd-catalyzed oxidation of alcohol towards an important aldehyde precursor in the synthesis of phosphatidylinositide 3-kinase inhibitor (CPL302415)
Herein, we describe the development of a green, scalable flow Pd-catalyzed aerobic oxidation for the key step in the synthesis of CPL302415, which is a new PI3Kδ inhibitor. Applying this environmental-friendly, sustainable catalytic oxidation we significantly increased product yield (up to 84%) and...
Autores principales: | Michałek, Stanisław, Gurba-Bryśkiewicz, Lidia, Maruszak, Wioleta, Zagozda, Marcin, Maj, Anna M., Ochal, Zbigniew, Dubiel, Krzysztof, Wieczorek, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682622/ https://www.ncbi.nlm.nih.gov/pubmed/36505705 http://dx.doi.org/10.1039/d2ra07003k |
Ejemplares similares
-
Tuning the Biological Activity of PI3Kδ Inhibitor by the Introduction of a Fluorine Atom Using the Computational Workflow
por: Pietruś, Wojciech, et al.
Publicado: (2023) -
Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery
por: Gurba-Bryśkiewicz, Lidia, et al.
Publicado: (2023) -
Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II—Benzimidazole Derivatives
por: Stypik, Mariola, et al.
Publicado: (2022) -
Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies
por: Gurba-Bryśkiewicz, Lidia, et al.
Publicado: (2022) -
Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I—Indole Derivatives
por: Stypik, Mariola, et al.
Publicado: (2022)